These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754 [TBL] [Abstract][Full Text] [Related]
23. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts. Yu H; Cai JJ; Lee HC Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893 [TBL] [Abstract][Full Text] [Related]
24. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
25. Resolution of soluble rat cardiac phosphodiesterases by high performance liquid chromatography. Bode DC; Kanter JR; Brunton LL Second Messengers Phosphoproteins; 1988-1989; 12(5-6):235-40. PubMed ID: 2856111 [TBL] [Abstract][Full Text] [Related]
26. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles]. Lazarevich VG; Men'shikov MIu; Tkachuk VA Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768 [TBL] [Abstract][Full Text] [Related]
27. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes. Hoskins B; Luong HB Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381 [TBL] [Abstract][Full Text] [Related]
28. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Weishaar RE; Burrows SD; Kobylarz DC; Quade MM; Evans DB Biochem Pharmacol; 1986 Mar; 35(5):787-800. PubMed ID: 3006691 [TBL] [Abstract][Full Text] [Related]
29. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Souness JE; Diocee BK; Martin W; Moodie SA Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related]
31. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity. Heber D; Heers C; Ravens U Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456 [TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Rose RJ; Liu H; Palmer D; Maurice DH Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930 [TBL] [Abstract][Full Text] [Related]
33. Stimulation of hamster adipocyte cyclic 3':5'-nucleotide phosphodiesterase activity by ionophore A23187 and calcium. Nemecek GM J Cyclic Nucleotide Res; 1978 Aug; 4(4):299-309. PubMed ID: 214467 [TBL] [Abstract][Full Text] [Related]
34. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. Muller B; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369 [TBL] [Abstract][Full Text] [Related]
36. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines. Mushlin P; Boerth RC; Wells JN Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531 [No Abstract] [Full Text] [Related]
37. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708 [TBL] [Abstract][Full Text] [Related]
38. Characterization of various horse thyroid forms of cyclic-nucleotide phosphodiesterase [proceedings]. Erneux C; Couchie D Arch Int Physiol Biochim; 1979 May; 87(2):408-10. PubMed ID: 92956 [No Abstract] [Full Text] [Related]
39. Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge. Kobayashi M; Nakamura H; Kobayashi J; Ohizumi Y J Pharmacol Exp Ther; 1991 Apr; 257(1):82-9. PubMed ID: 1850480 [TBL] [Abstract][Full Text] [Related]